Search Page

1

From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Henry C, Palm AE, Krammer F, Wilson PC. Henry C, et al. Trends Immunol. 2018 Jan;39(1):70-79. doi: 10.1016/j.it.2017.08.003. Epub 2017 Aug 31. Trends Immunol. 2018. PMID: 28867526 Free PMC article. Review.

Cite

Share

2

Development of a Universal Influenza Vaccine.

Estrada LD, Schultz-Cherry S. Estrada LD, et al. J Immunol. 2019 Jan 15;202(2):392-398. doi: 10.4049/jimmunol.1801054. J Immunol. 2019. PMID: 30617121 Free PMC article. Review.

Cite

Share

3

New fronts emerge in the influenza cytokine storm.

Guo XJ, Thomas PG. Guo XJ, et al. Semin Immunopathol. 2017 Jul;39(5):541-550. doi: 10.1007/s00281-017-0636-y. Epub 2017 May 29. Semin Immunopathol. 2017. PMID: 28555383 Free PMC article. Review.

Cite

Share

4

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Li Q, et al. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29. N Engl J Med. 2020. PMID: 31995857 Free article.

Cite

Share

5

Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.

Russell CJ, Hu M, Okda FA. Russell CJ, et al. Trends Microbiol. 2018 Oct;26(10):841-853. doi: 10.1016/j.tim.2018.03.005. Epub 2018 Apr 19. Trends Microbiol. 2018. PMID: 29681430 Free PMC article. Review.

Cite

Share

6

Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity.

Guo XJ, Dash P, Crawford JC, Allen EK, Zamora AE, Boyd DF, Duan S, Bajracharya R, Awad WA, Apiwattanakul N, Vogel P, Kanneganti TD, Thomas PG. Guo XJ, et al. Immunity. 2018 Sep 18;49(3):531-544.e6. doi: 10.1016/j.immuni.2018.07.011. Epub 2018 Aug 28. Immunity. 2018. PMID: 30170813 Free PMC article.

Cite

Share

7

The ecology and adaptive evolution of influenza A interspecies transmission.

Joseph U, Su YC, Vijaykrishna D, Smith GJ. Joseph U, et al. Influenza Other Respir Viruses. 2017 Jan;11(1):74-84. doi: 10.1111/irv.12412. Epub 2016 Aug 8. Influenza Other Respir Viruses. 2017. PMID: 27426214 Free PMC article. Review.

Cite

Share

8

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Krammer F, Fouchier RAM, Eichelberger MC, Webby RJ, Shaw-Saliba K, Wan H, Wilson PC, Compans RW, Skountzou I, Monto AS. Krammer F, et al. mBio. 2018 Apr 3;9(2):e02332-17. doi: 10.1128/mBio.02332-17. mBio. 2018. PMID: 29615508 Free PMC article. Review.

Cite

Share

9

CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Sant AJ, DiPiazza AT, Nayak JL, Rattan A, Richards KA. Sant AJ, et al. Immunol Rev. 2018 Jul;284(1):91-105. doi: 10.1111/imr.12662. Immunol Rev. 2018. PMID: 29944766 Free PMC article. Review.

Cite

Share

10

Novel correlates of protection against pandemic H1N1 influenza A virus infection.

Ng S, Nachbagauer R, Balmaseda A, Stadlbauer D, Ojeda S, Patel M, Rajabhathor A, Lopez R, Guglia AF, Sanchez N, Amanat F, Gresh L, Kuan G, Krammer F, Gordon A. Ng S, et al. Nat Med. 2019 Jun;25(6):962-967. doi: 10.1038/s41591-019-0463-x. Epub 2019 Jun 3. Nat Med. 2019. PMID: 31160818 Free PMC article. Clinical Trial.

Cite

Share